FDA approves Biosense's ablation catheter:
This article was originally published in Clinica
Executive Summary
The FDA has approved Biosense Webster's Navi-Star temperature ablation catheter for sale in the US. The device is designed for use with the company's Carto electrophysiological mapping system. Together they provide the only three-dimensional mapping technology on the market that combines real-time catheter location and radiofrequency (RF) temperature ablation in a single procedure, claims Biosense. The catheter integrates reproducible pinpoint location and accurate catheter positioning for safe and precise RF ablation procedures, says Diamond Bar, California-based Biosense, a Johnson & Johnson company.